Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferropink Drops is an oral pediatric nutritional supplement developed and marketed by Puneet Laboratories. It is formulated as oral drops containing a combination of ferrous bisglycinate, zinc bisglycinate, folic acid, cyanocobalamin (vitamin B12), and L-lysine. Ferrous bisglycinate is a highly bioavailable, chelated form of iron that is gentle on the stomach and effectively treats iron deficiency anemia. Zinc bisglycinate supports immune function and enzymatic processes, while folic acid and cyanocobalamin are essential for red blood cell maturation and DNA synthesis. L-lysine, an essential amino acid, supports protein synthesis, growth, and development. Ferropink Drops is primarily indicated for the prevention and treatment of iron deficiency anemia, nutritional anemia, and to support rapid growth and development in infants and children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ferropink Drops.